Search results
Results From The WOW.Com Content Network
The company is also cutting costs, targeting at least $4 billion in net savings by the end of 2024. Patience may be required as pipeline programs advance and COVID headwinds abate.
Despite constant attempts by analysts and the media to complicate the basics of investing, there are really only three ways a stock can create value for its shareholders: Dividends. Earnings growth.
Pfizer's (PFE) fourth-quarter earnings and sales beat estimates. Its forecast for 2019 falls short of expectations. Stock dips 2% in pre-market trading.
For premium support please call: 800-290-4726 more ways to reach us
Pfizer last year renegotiated a U.S. contract, allowing the government to return unused Paxlovid inventory. It recorded a $771 million favorable adjustment in the quarter, related to the U.S ...
AlamyBy Arthur Allen | KHNThe grinding two-plus years of the pandemic have yielded outsize benefits for one company—Pfizer—making it both highly influential and hugely profitable as covid-19 ...
Investors fled Pfizer last year as pandemic worries declined and billions of dollars in COVID-19 vaccine and treatment sales disappeared. Pfizer posts surprise 4th quarter profit, but key products ...
Pfizer (PFE) suffers massively in 2019 due to aggressive business development activity, incremental currency woes and loss of exclusivity of key drug Lyrica. But it is poised to have a better 2020.